Related Experiment Video
Updated: Oct 1, 2025

09:39
Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
Published on: July 29, 2016
15.6K
Cutaneous findings in myotonic dystrophy.
Ha Eun Kong1, Brian P Pollack2,1,3,4
1Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia.
JAAD International
|March 4, 2022
Summary
Myotonic dystrophy, a genetic disorder, presents with various skin issues, including hair loss and tumors. Dermatologists must recognize these cutaneous findings for accurate diagnosis and treatment.
Area of Science:
- Genetics
- Dermatology
- Molecular Biology
Background:
- Myotonic dystrophy (DM) types 1 and 2 are genetic disorders caused by nucleotide repeat expansions in the DMPK gene.
- DM affects multiple organs, with common skin manifestations including early male frontal alopecia and adult-onset pilomatricomas.
- DM increases the risk of skin cancers like basal cell carcinoma and melanoma.
Purpose of the Study:
- To review the cutaneous manifestations of myotonic dystrophy types 1 and 2.
- To summarize potential pathogenic mechanisms underlying these skin conditions.
- To inform dermatologists about DM-related skin findings for improved patient care.
Main Methods:
- Systematic PubMed search using keywords: "myotonic dystrophy," "cutaneous" OR "skin" OR "dermatologic," and "manifestation" OR "finding."
- Manual review of retrieved publications for relevance and identification of additional sources.
- Subsequent literature searches focusing on molecular pathogenesis.
Main Results:
- Common skin findings in DM include early-onset male frontal alopecia and pilomatricomas.
- Increased risk of basal cell carcinoma and melanoma is associated with myotonic dystrophy.
- The review synthesizes current knowledge on DM's dermatologic impact.
Conclusions:
- Dermatologists need awareness of DM's diverse cutaneous manifestations for timely diagnosis.
- Understanding pathogenic mechanisms can guide future therapeutic strategies.
- This review provides a comprehensive overview for clinical practice and research.
Related Concept Videos
Disorders of the Skeletal Muscle
1.2K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.2K
Satellite Stem Cells and Muscular Dystrophy
2.1K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.1K
Myasthenia Gravis: Diagnostic Tests
1.5K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.5K
Microscopic Anatomy of Skeletal Muscles
17.1K
Skeletal muscle cells, also called muscle fibers, are distinctly elongated, multi-nucleated, slender biological units. They are packed with specialized structures designed to facilitate their primary function, which is contraction.
The muscle sarcolemma is a plasma membrane enclosing each muscle cell that conducts electrical signals called action potentials. The sarcolemma extends into the cell to form T-tubules, ensuring the neural impulses are uniformly distributed across the entire muscle...
The muscle sarcolemma is a plasma membrane enclosing each muscle cell that conducts electrical signals called action potentials. The sarcolemma extends into the cell to form T-tubules, ensuring the neural impulses are uniformly distributed across the entire muscle...
17.1K
Skeletal Muscle Anatomy
90.0K
Skeletal muscle is the most abundant type of muscle in the body. Tendons are the connective tissue that attaches skeletal muscle to bones. Skeletal muscles pull on tendons, which in turn pull on bones to carry out voluntary movements.
90.0K
Myasthenia Gravis: Overview and Treatment
2.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.1K

